Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer
Original Article
R.J. Kelly, J.A. Ajani, J. Kuzdzal, T. Zander, E.V. Cutsem, G. Piessen, G. Mendez, J. Feliciano, S. Motoyama, A. Lièvre, H. Uronis, E. Elimova, C. Grootscholten, K. Geboes, S. Zafar, S. Snow, A.H. Ko, K. Feeney, M. Schenker, P. Kocon, J. Zhang, L. Zhu, M. Lei, P. Singh, K. Kondo, J.M. Cleary, and M. Moehler
N Engl J Med 2021;384:1191-1203
Available Credit
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Course closed
This course closed on Saturday, April 1, 2023 - 11:59pm.